186 related articles for article (PubMed ID: 10603649)
21. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
22. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
23. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
24. New approaches to cancer therapies.
Fåhraeus R; Fischer P; Krausz E; Lane DP
J Pathol; 1999 Jan; 187(1):138-46. PubMed ID: 10341714
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.
Maeda T; Matsubara H; Koide Y; Sugaya M; Miyazawa Y; Tasaki K; Isono K; Ochiai T; Sakiyama S; Tagawa M
Anticancer Res; 2000; 20(2A):869-74. PubMed ID: 10810368
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
27. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
28. Different approaches in the gene therapy of cancer.
Gough MJ; Vile RG
Forum (Genova); 1999; 9(3):225-36. PubMed ID: 10504170
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
30. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
31. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
32. Basics of cancer gene therapy.
Runnebaum IB
Anticancer Res; 1997; 17(4B):2887-90. PubMed ID: 9329555
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.
McNeish IA; Bell SJ; Lemoine NR
Gene Ther; 2004 Mar; 11(6):497-503. PubMed ID: 14762396
[TBL] [Abstract][Full Text] [Related]
34. Current status of gene therapy for lung cancer and head and neck cancer.
Moon C; Oh Y; Roth JA
Clin Cancer Res; 2003 Nov; 9(14):5055-67. PubMed ID: 14613982
[TBL] [Abstract][Full Text] [Related]
35. [p53: prospects for gene therapy of cancer].
Soddu S; Sacchi A
Clin Ter; 1998; 149(4):289-95. PubMed ID: 9866891
[TBL] [Abstract][Full Text] [Related]
36. [Review of cancer gene therapy].
Tani K
Nihon Geka Gakkai Zasshi; 2000 Sep; 101(9):618-24. PubMed ID: 11022677
[TBL] [Abstract][Full Text] [Related]
37. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
[TBL] [Abstract][Full Text] [Related]
38. Non-viral gene delivery for p53.
Pirollo KF; Xu L; Chang EH
Curr Opin Mol Ther; 2000 Apr; 2(2):168-75. PubMed ID: 11249638
[TBL] [Abstract][Full Text] [Related]
39. Gene Replacement Strategies for Lung Cancer.
Roth JA; Mukhopadhyay T; Zhang WW; Fujiwara T; Georges R
Semin Radiat Oncol; 1996 Apr; 6(2):105-109. PubMed ID: 10717169
[TBL] [Abstract][Full Text] [Related]
40. The basis for somatic gene therapy of cancer.
DeCruz EE; Walker TL; Dass CR; Burton MA
J Exp Ther Oncol; 1996 Mar; 1(2):73-83. PubMed ID: 9414390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
